# Comparing the Efficacy of VHAG and Traditional Chemotherapy Regimens in Newly Diagnosed ETP-ALL

> **NCT06361329** · PHASE3 · RECRUITING · sponsor: **First Affiliated Hospital of Zhejiang University** · enrollment: 81 (estimated)

## Conditions studied

- ETP-ALL

## Interventions

- **DRUG:** Homoharringtonine
- **DRUG:** venetoclax
- **DRUG:** Cytarabine
- **DRUG:** G-CSF
- **DRUG:** Vindesine
- **DRUG:** Daunorubicin
- **DRUG:** cyclophosphamide
- **DRUG:** Dexamethasone
- **DRUG:** L-ASP

## Key facts

- **NCT ID:** NCT06361329
- **Lead sponsor:** First Affiliated Hospital of Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-03
- **Primary completion:** 2026-03-31
- **Final completion:** 2027-03-31
- **Target enrollment:** 81 (ESTIMATED)
- **Last updated:** 2025-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06361329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06361329, "Comparing the Efficacy of VHAG and Traditional Chemotherapy Regimens in Newly Diagnosed ETP-ALL". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06361329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*